PPT-Asthma and COPD

Lauren Clark Outline Introduction Definition Epidemiology Etiology Cost amp Burden Intervention Research Introduction Chronic Lower Respiratory Diseases Chronic lower respiratory diseases. Asthma and COPD. Dr Rickbir Singh Randhawa. FY1. Definition:. Asthma. Chronic inflammatory airway disease characterised by . reversible airway obstruction. , airway hyper-responsiveness and bronchial inflammation. . Asthma & COPD. Rachel Ventre FY1. Spirometry/ PFT. Obstructive – .  . FEV1/FVC ratio. Asthma. COPD. Bronchiectasis. CF. Restrictive – . . FVC & FEV1. Normal or . . ratio.. Kyphosis/Scoliosis. D. aryl Freeman. on behalf of the Study Collaborators . Collaborators. Research in Real Life, Cambridge . David Price. Julie von . Ziegenweidt. Laurence . Mascarenhas. Annie Burden. Alison Chisholm. By Laura Parker. Learning Objectives. To be able to define Asthma and COPD. To have an understanding of the pathogenesis of each disease and the common causes / risk factors associated. To be able to recognise the presentation of patient with Asthma or COPD. SDMH EMC 2015. 1 - Asthma. Objectives. Understand assessment of acute asthma in adults. Outline management strategy dependent upon severity. Approach to initial management of the severe asthmatic. Safe discharge of the asthmatic patient. Community Healthcare. . Integrated . Paramedicine Project . Goal. Paramedics (and the EMT's assisting them) . Become home-health / public-health-minded clinicians. Perform home visits for those with chronic diseases . Outline . Introduction. Definition. Epidemiology. Etiology. Cost & Burden. Intervention. Research. Introduction. Chronic Lower Respiratory Diseases. Chronic lower respiratory diseases. : . Asthma, bronchitis, COPD, emphysema, cystic fibrosis, bronchiectasis, pneumoconiosis, sleep apnea. Finlay . Royle. Senior Clinical Commissioning Pharmacist. Lambeth CCG. 1. Medicines Optimisation . Key theme: . Quality. , . Safety . and . Medicines . W. aste. 2. Medicines are the most common therapeutic intervention in healthcare, but their use is often . Dr Rickbir Singh Randhawa. FY1. Definition:. Asthma. Chronic inflammatory airway disease characterised by . reversible airway obstruction. , airway hyper-responsiveness and bronchial inflammation. . Three factors contribute to reversible airway narrowing:. in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. in the Treatment of . Asthma and COPD. Margaret Miklich, . PharmD. , BCACP. Clinical Assistant Professor. 1. m. argaret.miklich@temple.edu. I have no conflicts of interest to disclose.. 2. Pharmacist Objectives. 80 predicted and sometimes but not always Stage II Moderate COPD Worsening airflow limitation FEVbreath typically developing during exertion This is the stage at which patients typically seek medical Dr Victor Duong. Senior Medical Registrar. Northern Health. Asthma. Overview. Initial assessment and management in the ED. Inpatient management. Preparing for discharge. What is not covered. Diagnostic aspects. Offer MUR / NMS where appropriate, does the patient meet the criteria for a referral to COPD Team (see reverse). Does the patient have a self-management plan (including advice on access to a rescue pack*)?.